OBJECTIVES: The control of blood glucose improves the long term outcomes for patients with type 2 diabetes; this study examined the levels of glycemic control in a clinic at MSFHCC, Saudi Arabia. METHODS: Data were obtained from patient medical records. All patients who met the inclusion criteria: (with type 2 diabetes, made at least four visits during one year, had their glycated hemoglobin (A1c) level been checked), the time frame for sampling is 18 months ending in December 2007. Descriptive statistics, logistics regression, and ANOVA were used in the analysis. RESULTS: Four hundred nine patients' records met the inclusion criteria, male are 64.7% of the sample, the means for age, A1c, BMI, and the duration of the DM were 53.4, 8.3%, 30.6 and 9.3 years, respectively. A total of 24.9% of the sample has A1c at the target control level(<7%), the test of differences of means of age, BMI and Duration of having DM across the levels of A1c (controlled , not well controlled (7%≤A1c<8.5), and poorly controlled (A1c≥8.5)) did show consistent results except BMI variable, group at the controlled HbA1c level has significant higher BMI means than the group with poorly controlled A1c level. 13.2 % of the sample treated with oral monotherapy antidiabetic drugs, 25.6% with a combination of Insulin and Metformin, and the rest were with multitherapy. In the logistic regression model, the type of therapy and the duration of diabetes were significant predictors for whether patient has controlled A1c level. CONCLUSIONS:The high rate of uncontrolled diabetic patients is an evidence of shortcoming. Large data might provide much and precise information to explain this high rate. The unexpected relationship between BMI and A1c level which noticed in controlled group could be explained by short duration of diabetes, early aggressive therapy regimens or other pathophysiological factors. Further follow up of such controlled group may provide an explanation of such relationship.